Keywords Nyctanthes arbor-tristis · Diabetic nephropathy · Hyperlipidemia · Anti-oxidant enzymes · Inflammatory markers 1 3 Nyctanthes arbor‑tristis leaf extract ameliorates hyperlipidemia‑ and… 1417 of these medicines is also a big concern (Agrawal and Introduction Pal, 2013). Despite tremendous improvements in medical science, there still lacks a single effective group of anti- Diabetes mellitus is an endocrine-related metabolic disor- diabetic drugs which also possess hypolipidemic proper- der where there is a persistent augment in blood glucose ties. Therefore, hunt for an intact, superior and competent level (hyperglycemia) with impairments in insulin secre- hypoglycemic agent always remains a challenged having tion, action or both (Ahmed et al. 2016). Diabetes has low cost with minimal adverse effects. Plant formulations now become a major global saddle today affecting mostly have gained its popularity due to minimum toxicity, easy the developing countries. As of 2015, India has become accessibility, and ready availability with multiple molecu- the diabetic hub with 69.2 million diabetic people and is lar targets. ranked second in the world (Unnikrishnan et al. 2016). If Nyctanthes arbor-tristis L. (family: Oleaceae), fre- the problem is not resolved, then India will become a land quently known as night-flowering Jasmine (English) or with 87 million diabetic people by 2030,
Inflammopharmacology – Springer Journals
Published: Jun 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera